A groundbreaking shift in Canadian drug policy has happened, as the authorities allow the availability of psilocybin hallucinogens for therapeutic purposes. Previously, these substances were heavily restricted, but a growing body of evidence suggests they may offer aid for mental health illnesses like PTSD. This change represents a key step toward